About this medicine
- Approved name
- Lartruvo
- International non-proprietary name (INN) or common name
- olaratumab
- Associated names
- Lartruvo
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-20/1479/C/4216/015
- Type
- Article 20 procedures
This type of procedure is triggered for medicines that have been authorised via the centralised procedure in case of quality, safety or efficacy issues.
- Authorisation model
- Centrally authorised product(s)
Key dates and outcomes
- CHMP opinion date
- 31/01/2019
- EC decision date
- 19/07/2019